Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders

Background: The treatment of Helicobacter pylori (HP) infection in patients with diabetes mellitus with chronic gastroduodenal disorders is a substantial problem because of its high incidence. Aims: To compare between the effectiveness of triple and optimised consecutive regimens in anti-HP treatme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuri L. Fedorchenko, Marina V. Martynuk
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2017
Materias:
Acceso en línea:https://doaj.org/article/07b73f764aa1449e81dddb0d3578d44f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:07b73f764aa1449e81dddb0d3578d44f
record_format dspace
spelling oai:doaj.org-article:07b73f764aa1449e81dddb0d3578d44f2021-11-14T09:00:21ZTreatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders2072-03512072-037810.14341/DM8689https://doaj.org/article/07b73f764aa1449e81dddb0d3578d44f2017-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/8689https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Background: The treatment of Helicobacter pylori (HP) infection in patients with diabetes mellitus with chronic gastroduodenal disorders is a substantial problem because of its high incidence. Aims: To compare between the effectiveness of triple and optimised consecutive regimens in anti-HP treatment in patients with type 2 diabetes mellitus with gastroduodenal disorders. Materials and methods: The study included 54 patients with diabetes mellitus and 64 healthy individuals (the control group) aged 30–60 years. Gastroduodenal pathology was confirmed by gastroduodenoscopy; HР contamination was confirming using Marshall’s urease method or by finding bacterial antigen in excrements. We studied the dynamics of clinical manifestations using the GSRS scale and showed remission via endoscopy and the effectiveness of HР eradication. We also analysed the effects of anti-HР therapy regimens on the presence of small intestinal bacterial overgrowth syndrome (SIBOS) in patients with diabetes mellitus. SIBOS was diagnosed via the respiratory hydrogen method. Results: The use of an optimised consecutive regimen resulted in HР eradication in 85.7% of patients with diabetes mellitus compared with a 65.3% eradication in patients on the triple therapy. Moreover, clinical improvement and endoscopy-confirmed remission were more frequently observed in patients on the optimised consecutive regimen. A statistically significant decrease in the number of patients with SIBOS was found only in patients who underwent the optimised consecutive therapy regimen. Conclusions: This study showed that the optimised consecutive therapy regimen was more effective than the triple therapy in HP eradication.Yuri L. FedorchenkoMarina V. MartynukEndocrinology Research Centrearticlehelicobacterpylorydiabetes mellitusgastroduodenal diseasesNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 20, Iss 6, Pp 427-433 (2017)
institution DOAJ
collection DOAJ
language EN
RU
topic helicobacterpylory
diabetes mellitus
gastroduodenal diseases
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle helicobacterpylory
diabetes mellitus
gastroduodenal diseases
Nutritional diseases. Deficiency diseases
RC620-627
Yuri L. Fedorchenko
Marina V. Martynuk
Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
description Background: The treatment of Helicobacter pylori (HP) infection in patients with diabetes mellitus with chronic gastroduodenal disorders is a substantial problem because of its high incidence. Aims: To compare between the effectiveness of triple and optimised consecutive regimens in anti-HP treatment in patients with type 2 diabetes mellitus with gastroduodenal disorders. Materials and methods: The study included 54 patients with diabetes mellitus and 64 healthy individuals (the control group) aged 30–60 years. Gastroduodenal pathology was confirmed by gastroduodenoscopy; HР contamination was confirming using Marshall’s urease method or by finding bacterial antigen in excrements. We studied the dynamics of clinical manifestations using the GSRS scale and showed remission via endoscopy and the effectiveness of HР eradication. We also analysed the effects of anti-HР therapy regimens on the presence of small intestinal bacterial overgrowth syndrome (SIBOS) in patients with diabetes mellitus. SIBOS was diagnosed via the respiratory hydrogen method. Results: The use of an optimised consecutive regimen resulted in HР eradication in 85.7% of patients with diabetes mellitus compared with a 65.3% eradication in patients on the triple therapy. Moreover, clinical improvement and endoscopy-confirmed remission were more frequently observed in patients on the optimised consecutive regimen. A statistically significant decrease in the number of patients with SIBOS was found only in patients who underwent the optimised consecutive therapy regimen. Conclusions: This study showed that the optimised consecutive therapy regimen was more effective than the triple therapy in HP eradication.
format article
author Yuri L. Fedorchenko
Marina V. Martynuk
author_facet Yuri L. Fedorchenko
Marina V. Martynuk
author_sort Yuri L. Fedorchenko
title Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_short Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_full Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_fullStr Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_full_unstemmed Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_sort treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
publisher Endocrinology Research Centre
publishDate 2017
url https://doaj.org/article/07b73f764aa1449e81dddb0d3578d44f
work_keys_str_mv AT yurilfedorchenko treatmentofhelicobacterpyloricontaminationinpatientswithtype2diabetesmellituswithgastroduodenaldisorders
AT marinavmartynuk treatmentofhelicobacterpyloricontaminationinpatientswithtype2diabetesmellituswithgastroduodenaldisorders
_version_ 1718429507105325056